Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RA7qvApdOXJreV1CYr_xLbzpCjoaMWTWH1DBQkp-MBtVM#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _3 provenance.
- assertion hadPrimarySource 15477018 provenance.
- _3 wasQuotedFrom 15477018 provenance.
- _3 value "NHBE cells were pretreated with 0.5 to 5 ?M BAY 11-7082 before hyperoxic exposure. BAY 11-7082 is an irreversible NF-?B inhibitor that inhibits the IKK pathway to phosphorylate I?B, which is then degraded [24] and [25]. Figure 3 shows that pretreatment of NHBE cells with BAY 11-7082 accelerated hyperoxia-induced cell death. This accelerated loss of cell viability is independent of the presence of 0.5% DMSO, the vehicle for BAY 11-7082, because the extents of cell viability upon exposure to hyperoxia were similar in cells with or without 0.5% DMSO (Fig. 3). In contrast, an increase in the dose of BAY 11-7082 resulted in an incremental loss of cell viability in hyperoxia, indicating that inhibition of NF-?B can induce an accelerated, dose-dependent cell killing effect. These data suggest a protective role for NF-?B against hyperoxia-induced nonapoptotic cell death." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.